In the last trading session, 2.04 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) were traded, and its beta was 5.88. Most recently the company’s share price was $0.28, and it changed around -$0.02 or -8.20% from the last close, which brings the market valuation of the company to $2.23M. APVO currently trades at a discount to its 52-week high of $32.93, offering almost -11660.71% off that amount. The share price’s 52-week low was $0.24, which indicates that the current value has risen by an impressive 14.29% since then.
Aptevo Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended APVO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Instantly APVO has showed a red trend with a performance of -8.20% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.7167 on recent trading dayincreased the stock’s daily price by 60.93%. The company’s shares are currently down -93.61% year-to-date, but still down -13.94% over the last five days. On the other hand, Aptevo Therapeutics Inc (NASDAQ:APVO) is -60.18% down in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 80.96%. Aptevo Therapeutics Inc earnings are expected to increase by 81.87% in 2025, but the outlook is positive 51.40% per year for the next five years.
APVO Dividends
Aptevo Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 8.4 shares worth $2312.0, making up 0.26% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 668.0 shares worth around $183.0, which represents about 0.02% of the total shares outstanding.
